FOR LABORATORY RESEARCH ONLY Direct quotations · Minimum 1 box

Neuroscience research

Semax in spinal injury: testing lysosomal and ubiquitination pathways

A female-mouse spinal-injury model was combined with neuronal-cell experiments, sequencing and target-perturbation studies.

Preclinical studyPaper year: 2025Semax

01 / DESIGN

What was studied?

A female-mouse spinal-injury model was combined with neuronal-cell experiments, sequencing and target-perturbation studies.

02 / FINDINGS

What did the researchers report?

The authors reported improved selected recovery measures and proposed a pathway involving opioid-receptor signaling, USP18 and protein deubiquitination.

03 / LIMITS

How should it be interpreted?

Computational target suggestions and experimental pathway results differ in evidential strength. Findings in one sex and injury model do not establish human neurological treatment.

Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.

WhatsApp ↗